STOCK TITAN

IM Cannabis Announces Plans to Voluntarily Delist from the Canadian Securities Exchange

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Negative)
Tags

IM Cannabis (NASDAQ: IMCC) has announced its application for voluntary delisting from the Canadian Securities Exchange (CSE). The company's shares will continue trading on NASDAQ under the symbol "IMCC". The final trading day on CSE is expected to be June 2, 2025.

The decision is driven by several factors: potential transactions that would incur unnecessary costs and delays if listed on CSE, low trading volume on CSE that doesn't justify maintenance expenses, and the aim to create a centralized marketplace on Nasdaq to enhance long-term liquidity and shareholder value.

IM Cannabis (NASDAQ: IMCC) ha annunciato la sua richiesta di cancellazione volontaria dalla Canadian Securities Exchange (CSE). Le azioni della società continueranno a essere negoziate su NASDAQ con il simbolo "IMCC". L'ultimo giorno di contrattazione sulla CSE è previsto per il 2 giugno 2025.

La decisione è motivata da diversi fattori: potenziali operazioni che comporterebbero costi e ritardi inutili se quotate sulla CSE, il basso volume di scambi sulla CSE che non giustifica le spese di mantenimento, e l'obiettivo di creare un mercato centralizzato su Nasdaq per migliorare la liquidità a lungo termine e il valore per gli azionisti.

IM Cannabis (NASDAQ: IMCC) ha anunciado su solicitud de exclusión voluntaria de la Canadian Securities Exchange (CSE). Las acciones de la compañía seguirán cotizando en NASDAQ bajo el símbolo "IMCC". Se espera que el último día de negociación en la CSE sea el 2 de junio de 2025.

La decisión está motivada por varios factores: posibles transacciones que generarían costos y retrasos innecesarios si se mantuviera la cotización en la CSE, el bajo volumen de negociación en la CSE que no justifica los gastos de mantenimiento, y el objetivo de crear un mercado centralizado en Nasdaq para mejorar la liquidez a largo plazo y el valor para los accionistas.

IM Cannabis (NASDAQ: IMCC)는 캐나다 증권 거래소(CSE)에서 자발적 상장 폐지 신청을 발표했습니다. 회사 주식은 NASDAQ에서 "IMCC"라는 심볼로 계속 거래될 예정입니다. CSE에서의 마지막 거래일은 2025년 6월 2일로 예상됩니다.

이 결정은 여러 요인에 의해 이루어졌습니다: CSE에 상장된 상태로는 불필요한 비용과 지연이 발생할 수 있는 잠재 거래, 유지 비용을 정당화하지 못하는 낮은 CSE 거래량, 그리고 장기적인 유동성과 주주 가치를 높이기 위해 Nasdaq에 중앙화된 시장을 만들려는 목표 때문입니다.

IM Cannabis (NASDAQ : IMCC) a annoncé sa demande de radiation volontaire de la Canadian Securities Exchange (CSE). Les actions de la société continueront d’être négociées sur NASDAQ sous le symbole "IMCC". Le dernier jour de cotation sur la CSE est prévu pour le 2 juin 2025.

Cette décision est motivée par plusieurs facteurs : des transactions potentielles qui engendreraient des coûts et des retards inutiles si la société restait cotée à la CSE, un faible volume d’échanges sur la CSE ne justifiant pas les frais de maintien, ainsi que l’objectif de créer un marché centralisé sur le Nasdaq afin d’améliorer la liquidité à long terme et la valeur pour les actionnaires.

IM Cannabis (NASDAQ: IMCC) hat seine freiwillige Antragstellung für die Delistung von der Canadian Securities Exchange (CSE) bekanntgegeben. Die Aktien des Unternehmens werden weiterhin an der NASDAQ unter dem Symbol "IMCC" gehandelt. Der letzte Handelstag an der CSE wird voraussichtlich der 2. Juni 2025 sein.

Die Entscheidung basiert auf mehreren Faktoren: potenzielle Transaktionen, die unnötige Kosten und Verzögerungen verursachen würden, wenn die Aktie an der CSE gelistet bleibt, das geringe Handelsvolumen an der CSE, das die Aufrechterhaltungskosten nicht rechtfertigt, sowie das Ziel, einen zentralisierten Marktplatz an der Nasdaq zu schaffen, um die langfristige Liquidität und den Aktionärswert zu verbessern.

Positive
  • Consolidation to NASDAQ listing may improve trading liquidity
  • Reduction in administrative costs and regulatory burden by eliminating dual listing
  • Potential to execute transactions more efficiently without CSE requirements
Negative
  • Reduced trading venue options for shareholders
  • Potential impact on Canadian investor accessibility

TORONTO and GLIL YAM, Israel, May 28, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announces that it has applied for a voluntary delisting of its common shares ("Shares") from the Canadian Securities Exchange (the "CSE"). The delisting from the CSE will not affect the Company's listing on NASDAQ and its Shares will continue trading on the NASDAQ under the symbol "IMCC".

IM Cannabis Corp Logo

The Company is entertaining potential transactions that, if completed while the Company is listed on the CSE, would require the Company to incur unnecessary burdensome costs, approvals and delay. The Company believes that the trading volume of its Shares on the CSE no longer justifies the expenses, administrative efforts, and regulatory burdens required to maintain a dual listing. The Company also believes that delisting from the CSE will create a central marketplace for its Shares on the Nasdaq and ultimately benefit the long-term liquidity and shareholder value of the Company. All shareholders can continue trading IMC's shares on Nasdaq under the symbol "IMCC".

The Company is grateful to the CSE for providing its initial opportunity to access public markets. It is expected, subject to approval from the CSE, that the close of business on Monday, June 2, 2025, will be the final trading day for IMC on the CSE.

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms and logistical hubs in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients.

Forward Looking Information

This press release contains certain "forward-looking statements" within the meaning of Canadian securities law. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, identified by words or phrases such as "believes", "anticipates", "expects", "is expected", "scheduled", "estimates", "pending", "intends", "plans", "forecasts", "targets", or "hopes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "will", "should" "might", "will be taken", or "occur" and similar expressions) are not statements of historical fact and may be forward-looking statements. Forward-looking information herein includes, but is not limited to, statements that address activities, events or developments that the Company expects or anticipates will or may occur in the future including the Company's potential delisting from the CSE, the Company's expectation that its Shares will be delisted from the CSE; the Company ceasing to file reports to the CSE after delisting; and the Company's expectation that its Shares will continue trading on the NASDAQ.

The Company cautions that forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made, and they involve a number of risks and uncertainties. Consequently, there can be no assurances that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Except to the extent required by applicable securities laws and the policies of the Canadian Securities Exchange, the Company undertakes no obligation to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors, should change. Factors that could cause future results to differ materially from those anticipated in these forward-looking statements include risks associated with the Company's potential delisting from the CSE; the Company ceasing to file reports to the CSE; the Company's ability to relist on the CSE in the future; the timing and receipt of certain approvals from the CSE pertaining to the delisting; and the anticipated benefits associated with delisting.

The reader is urged to refer to additional information relating to IMC, including its annual information form, can be located on the SEDAR+ website at www.sedarplus.ca and on the EDGAR section of the SEC's website at www.sec.gov for a more complete discussion of such risk factors and their potential effects.

This list of risk factors should not be construed as exhaustive. The Company does not undertake any obligation to publicly update or revise any forward-looking statements or information contained herein, except as required by applicable laws. The forward-looking statements contained in this document are expressly qualified by this cautionary statement.

Company Contact:

Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
a.taranko@imcannabis.de 

Oren Shuster, CEO
IM Cannabis Corp.
+972-77-3603504
info@imcannabis.com

Logo - https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

Cision View original content:https://www.prnewswire.com/news-releases/im-cannabis-announces-plans-to-voluntarily-delist-from-the-canadian-securities-exchange-302466961.html

SOURCE IM Cannabis Corp.

FAQ

Why is IM Cannabis (IMCC) delisting from the Canadian Securities Exchange?

IM Cannabis is delisting from CSE due to low trading volumes that don't justify expenses, potential transaction efficiency, and to create a centralized marketplace on NASDAQ to improve liquidity and shareholder value.

When will IMCC stock stop trading on the Canadian Securities Exchange?

Subject to CSE approval, IMCC's final trading day on the Canadian Securities Exchange will be Monday, June 2, 2025.

Can investors still trade IMCC stock after CSE delisting?

Yes, investors can continue trading IM Cannabis shares on NASDAQ under the symbol 'IMCC' after the CSE delisting.

What are the benefits of IMCC delisting from CSE?

Benefits include reduced administrative costs, streamlined regulatory compliance, potential for more efficient transaction execution, and creation of a centralized marketplace on NASDAQ for better liquidity.
Im Cannabis Corp

NASDAQ:IMCC

IMCC Rankings

IMCC Latest News

IMCC Stock Data

5.31M
1.86M
43.88%
3.91%
0.26%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Israel
Tel Aviv